GAMMA Investing »

Y Mabs Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $422 26 16.27

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Point72 Asset Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Boothbay Fund Management
Northern Trust

View all funds holding Y Mabs Therapeutics